Showing results (221-230 of 293) with videos related to

Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancerMichael J Morris, Chaitanya R Divgi, Neeta Pandit-Taskar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancerMichael J Morris, Neeta Pandit-Taskar, Jorge Carrasquillo, et al.
Pediatric Blood & Cancer|July 2, 2020
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastomaLeo Y Luo, Kim Kramer, Nai-Kong V Cheung, et al.
Pediatric Blood & Cancer|March 10, 2010
Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastomaSonal Bhandari, Nai-Kong V Cheung, Brian H Kushner, et al.
International Journal of Cancer|September 22, 2016
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastomaBrian H Kushner, Nai-Kong V Cheung, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2020
Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease ProgressionIrene Y Cheung, Nai-Kong V Cheung, Shakeel Modak, et al.
Journal of Pediatric Hematology/Oncology|August 23, 2024
Omalizumab for Treatment of Anti-GD2 Antibody-related UrticariaRachel Glincher, Angela Lentini-Rivera, Latisha Andre Jones, et al.
Journal of Nuclear Medicine Technology|July 15, 2025
2024 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical ActivitiesS Ted Treves, Frederic H Fahey, Valentina Ferrer Valencia, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2019
Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective TrialDana L Casey, Brian H Kushner, Nai-Kong V Cheung, et al.
Pageof 30